Lahore faces a severe health crisis as influenza vaccine became virtually unavailable across retail pharmacies, following an earlier acute shortage of insulin. Local medical store operators reported that major international pharmaceutical brands failed to supply seasonal flu vaccines to the Pakistani market this year. Consequently, elderly citizens and vulnerable patients suffering from chronic illnesses face significant difficulties obtaining essential preventative immunizations. Medical experts strongly advise senior citizens to receive flu vaccinations annually during September to boost immunity before winter sets in. However, the widespread shortage leaves thousands of vulnerable individuals unprotected against seasonal respiratory infections as weather patterns shift.
Read More: Asia offers more flu shots to head off COVID-19 complications
Pharmacy owners confirmed that only a single Chinese pharmaceutical manufacturer managed to import a limited batch of influenza vaccines into the domestic market recently. However, the available supply remains drastically insufficient to meet the rising medical demand across the provincial capital. Due to the severe supply-demand imbalance, retail prices for the imported Chinese vaccine surged from 1,200 rupees to 1,640 rupees per dose. Pharmacists noted that persistent supply chain disruptions and import constraints continue inflating prices for critical life-saving medicines across Punjab. Therefore, low-income families and elderly pensioners struggle to afford basic preventative healthcare options.
The fresh vaccine shortage exacerbates existing public health challenges across Lahore. Atmospheric pollution and winter smog already drive a sharp increase in respiratory illnesses. Earlier this month, patients experienced severe difficulties procuring essential insulin products, forcing health authorities to investigate supply chain bottlenecks. The NIH previously issued comprehensive advisories urging provincial healthcare departments to ensure adequate stocks of seasonal flu vaccines. Nevertheless, retail markets continue experiencing persistent shortages, leaving public and private hospitals struggling to meet patient requirements.
Health advocacy groups and consumer rights organizations urged Ministry of National Health Services and Drug Regulatory Authority of Pakistan to intervene immediately. Civil society representatives demanded strict regulatory oversight to prevent hoarding and price gouging by commercial distributors exploiting the supply deficit. Medical professionals emphasized that timely immunization remains crucial to prevent overcrowded hospital emergency rooms during the peak winter flu season. Consequently, health officials face mounting pressure to streamline import procedures and secure emergency vaccine shipments.
Read More: Flu nasal spray just as effective as flu shot
Provincial health department authorities maintain that efforts are underway to coordinate with pharmaceutical importers to restore stable medicine supplies across major cities. Regulators warned retail pharmacy managers against selling essential vaccines above official government-notified retail prices. Public health experts stress that long-term domestic manufacturing capabilities are essential to prevent recurring shortages of vital vaccines and insulin.